Sousa RH, Souza LL, Guedes PT, Prado-Ribeiro AC, Rodrigues-Oliveira L, Brandão TB, et al. Oral Kaposi sarcoma development is associated with HIV viral load, CD4+ count and CD4+/CD8+ ratio. Med Oral Patol Oral Cir Bucal. 2021 Nov 1;26 (6):e748-53.
doi:10.4317/medoral.24708
https://dx.doi.org/doi:10.4317/medoral.24708
1. Semango GP, Charles RM, Swai CI, Mremi A, Amsi P, Sonda T, et al. Prevalence and associated risk factors for Kaposi's sarcoma among HIV-positive patients in a referral hospital in Northern Tanzania: a retrospective hospital-based study. BMC Cancer. 2018;18:1258. |
PMid:30558571 PMCid:PMC6296123 |
2. Agaimy A, Mueller SK, Harrer T, Bauer S, Thompson LDR. Head and neck Kaposi sarcoma: clinicopathological analysis of 11 cases. Head Neck Pathol. 2018;12:511-6. |
PMid:29508130 PMCid:PMC6232196 |
3. Bhutani M, Polizzotto MN, Uldrick TS, Yarchoan R. Kaposi sarcoma-associated herpesvirus-associated malignancies: epidemiology, pathogenesis, and advances in treatment. Semin Oncol. 2015;42:223-46. |
PMid:25843728 PMCid:PMC6309362 |
4. Benevenuto de Andrade BA, Ramírez-Amador V, Anaya-Saavedra G, Martínez-Mata G, Fonseca FP, Graner E, et al. Expression of PROX-1 in oral Kaposi's sarcoma spindle cells. J Oral Pathol Med. 2014;43:132-6. |
PMid:23763431 |
5. Garzino-Demo P, Mettus A, Passalacqua F, Vittone F, Ramieri G. Oral localization of Kaposi sarcoma: clinical presentation and conservative management. J Craniofac Surg. 2017;28:e545-e7. |
PMid:28708648 |
6. Gupta K, Tun A, Gupta A, Berkowitz LB, Anwar R, Liu Y, et al. A case of classic Kaposi sarcoma in an immunocompetent human immunodeficiency virus-negative Dominican man. SAGE Open Med Case Rep. 2020;8:2050313X20938249. |
PMid:32670583 PMCid:PMC7339073 |
7. Khammissa RA, Pantanowitz L, Feller L. Oral HIV-associated Kaposi sarcoma: a clinical study from the Ga-Rankuwa area, South Africa. AIDS Res Treat. 2012;2012:873171. |
PMid:23008762 PMCid:PMC3447356 |
8. Pantanowitz L, Khammissa RA, Lemmer J, Feller L. Oral HIV-associated Kaposi sarcoma. J Oral Pathol Med. 2013;42:201-7. |
PMid:22672182 |
9. Sullivan RJ, Pantanowitz L, Casper C, Stebbing J, Dezube BJ. HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease. Clin Infect Dis. 2008;47:1209-15. |
PMid:18808357 PMCid:PMC2700291 |
10. Solivetti FM, Elia F, Latini A, Cota C, Cordiali-Fei P, Di Carlo A. AIDS-Kaposi Sarcoma and Classic Kaposi Sarcoma: are different ultrasound patterns related to different variants?. J Exp Clin Cancer Res. 2011;30:40. |
PMid:21489270 PMCid:PMC3095540 |
11. de Carvalho WRS, de Souza LL, Pontes FSC, Uchôa DCC, Corrêa DL, de Cáceres CVBL, et al. A multicenter study of oral sarcomas in Brazil. Oral Dis. 2020;26:43-52. |
PMid:31605560 |
12. Dai L, Qin Z, Defee M, Toole BP, Kirkwood KL, Parsons C. Kaposi sarcoma-associated herpesvirus (KSHV) induces a functional tumor-associated phenotype for oral fibroblasts. Cancer Lett. 2012;318:214-20. |
PMid:22186301 PMCid:PMC3303930 |
13. Lepone LM, Rappocciolo G, Piazza PA, Campbell DM, Jenkins FJ, Rinaldo CR. Regulatory T cell effect on CD8+ T cell responses to human herpesvirus 8 infection and development of Kaposi's sarcoma. AIDS Res Hum Retroviruses. 2017;33:668-74. |
PMid:28121161 PMCid:PMC5512339 |
14. Robey RC, Lagos D, Gratrix F, Henderson S, Matthews NC, Vart RJ, et al. The CD8 and CD4 T-cell response against Kaposi's sarcoma-associated herpesvirus is skewed towards early and late lytic antigens. PLoS One. 2009;4:e5890. |
PMid:19536280 PMCid:PMC2691989 |
15. Park LS, Hernández-Ramírez RU, Silverberg MJ, Crothers K, Dubrow R. Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis. AIDS. 2016;30:273-91. |
PMid:26691548 PMCid:PMC4689318 |
16. Dubrow R, Qin L, Lin H, Hernández-Ramírez RU, Neugebauer RS, Leyden W, et al. Association of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and Canada. J Acquir Immune Defic Syndr. 2017;75:382-90. |
PMid:28394855 PMCid:PMC5490794 |
17. Crum-Cianflone NF, Hullsiek KH, Ganesan A, Weintrob A, Okulicz JF, Agan BK. Infectious Disease Clinical Research Program HIV Working Group. Is Kaposi's sarcoma occurring at higher CD4 cell counts over the course of the HIV epidemic?. AIDS. 2010;24:2881-3. |
PMid:20827160 PMCid:PMC2978255 |
18. Taiwo OO, Hassan Z. The impact of Highly Active Antiretroviral Therapy (HAART) on the clinical features of HIV-related oral lesions in Nigeria. AIDS Res Ther. 2010;7:19. |
PMid:20579347 PMCid:PMC2903493 |
19. Guedes PTL, Pontes FSC, Prado-Ribeiro AC, Rodrigues-Oliveira L, Brandão TB, de Souza LL, et al. HIV Positive Patients with oral Kaposi's Sarcoma: An Overall Survival Analysis Of 31 Patients. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021;131:702-10. |
PMid:33741283 |
20. Little RF, Uldrick TS. Are there clues to oral Kaposi sarcoma-associated herpesvirus shedding and Kaposi sarcoma oncogenesis in the oral microbiome?. J Infect Dis. 2020;221:1226-28. |
PMid:31111901 PMCid:PMC7325795 |
21. Volkow P, Cesarman-Maus G, Garciadiego-Fossas P, Rojas-Marin E, Cornejo-Juárez P. Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma. AIDS Res Ther. 2017;14:30. |
PMid:28558783 PMCid:PMC5450046 |
22. Speicher DJ, Wanzala P, D'Lima M, Njiru A, Chindia M, Dimba E, et al. Diagnostic challenges of oral and cutaneous Kaposi's sarcoma in resource-constrained settings. J Oral Pathol Med. 2015;44:842-9. |
PMid:25782476 |
23. Gonçalves PH, Uldrick TS, Yarchoan R. HIV-associated Kaposi sarcoma and related diseases. AIDS. 2017;31:1903-16. |
PMid:28609402 PMCid:PMC6310482 |
24. Goncalves PH, Ziegelbauer J, Uldrick TS, Yarchoan R. Kaposi sarcoma herpesvirus-associated cancers and related diseases. Curr Opin HIV AIDS. 2017;12:47-56. |
PMid:27662501 PMCid:PMC6311702 |
25. Rezende RE, Kahwage RL, da Costa TV, Machado AA, Brunaldi MO, Kemp R, et al. Upper gastrointestinal Kaposi's sarcoma in HIV-infected patients: ten years of endoscopy observation at a single Brazilian center. Int J Infect Dis. 2015;39:110-5. |
PMid:26376222 |
26. Poizot-Martin I, Lions C, Cheret A, Rey D, Duvivier C, Jacomet C, et al. Kaposi sarcoma in people living with HIV: incidence and associated factors in a French cohort between 2010 and 2015. AIDS. 2020;34:569‐77. |
PMid:31764070 |
27. Dupont C, Vasseur E, Beauchet A, Aegerter P, Berthé H, de Truchis P, et al. Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d'information et de soins de l'immunodéficience humaine. AIDS. 2000;14:987-93. |
PMid:10853980 |
28. Zhang P, Wang J, Zhang X, Wang X, Jiang L, Gu X. Identification of AIDS-associated Kaposi sarcoma: a functional genomics approach. Front Genet. 2020;10:1376. |
PMid:32038721 PMCid:PMC6992650 |
29. Veettil MV, Bandyopadhyay C, Dutta D, Chandran B. Interaction of KSHV with host cell surface receptors and cell entry. Viruses. 2014;6:4024-46. |
PMid:25341665 PMCid:PMC4213576 |
30. Uppal T, Banerjee S, Sun Z, Verma SC, Robertson ES. KSHV LANA-the master regulator of KSHV latency. Viruses. 2014;6:4961-98. |
PMid:25514370 PMCid:PMC4276939 |